$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 11,000 | 0 | 1,559,742 | 1.6 M to 1.6 M (-0.70 %) |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 180,000 | 0 | 530,000 | 350 K to 530 K (+51.43 %) |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 5.41 | 70,000 | 378,700 | 70,000 | |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 35,000 | 0 | 90,798 | 55.8 K to 90.8 K (+62.73 %) |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | A | 5.41 | 90,000 | 486,900 | 90,000 | |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 0.00 | 45,000 | 0 | 211,219 | 166.2 K to 211.2 K (+27.07 %) |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 5.41 | 110,000 | 595,100 | 110,000 | |
Dec 10 2012 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 55,000 | 0 | 130,000 | 75 K to 130 K (+73.33 %) |
Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 50,800 | |
Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 55,798 | 70.8 K to 55.8 K (-21.19 %) |
Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 70,798 | 55.8 K to 70.8 K (+26.88 %) |
Nov 28 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.33 | 4,736 | 25,232 | 55,798 | 60.5 K to 55.8 K (-7.82 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.71 | 7,500 | 42,825 | 208,160 | 215.7 K to 208.2 K (-3.48 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.70 | 400 | 2,280 | 215,660 | 216.1 K to 215.7 K (-0.19 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.69 | 600 | 3,414 | 216,060 | 216.7 K to 216.1 K (-0.28 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.63 | 100 | 563 | 216,660 | 216.8 K to 216.7 K (-0.05 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.62 | 300 | 1,686 | 216,760 | 217.1 K to 216.8 K (-0.14 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.61 | 1,805 | 10,126 | 217,060 | 218.9 K to 217.1 K (-0.82 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.60 | 100 | 560 | 218,865 | 219 K to 218.9 K (-0.05 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.54 | 3,195 | 17,700 | 218,965 | 222.2 K to 219 K (-1.44 %) |
Dec 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.48 | 1,000 | 5,480 | 222,160 | 223.2 K to 222.2 K (-0.45 %) |
Nov 05 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.52 | 15,000 | 82,764 | 223,160 | 238.2 K to 223.2 K (-6.30 %) |
Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 65,800 | |
Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.72 | 5,000 | 28,600 | 58,534 | 63.5 K to 58.5 K (-7.87 %) |
Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 15,000 | 85,335 | 63,534 | 78.5 K to 63.5 K (-19.10 %) |
Oct 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | M | 3.61 | 15,000 | 54,150 | 78,534 | 93.5 K to 78.5 K (-16.04 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | VP, Therapeutic Dev ... | Option Exercise | M | 4.92 | 6,000 | 29,520 | 33,000 | |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | VP, Therapeutic Dev ... | Sell | S | 6.00 | 6,000 | 36,000 | 50,000 | 56 K to 50 K (-10.71 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | VP, Therapeutic Dev ... | Buy | M | 4.92 | 6,000 | 29,520 | 56,000 | 50 K to 56 K (+12.00 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.62 | 1,500 | 8,430 | 63,534 | 65 K to 63.5 K (-2.31 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.62 | 1,500 | 8,435 | 65,034 | 66.5 K to 65 K (-2.25 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 300 | 1,708 | 66,534 | 66.8 K to 66.5 K (-0.45 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.69 | 500 | 2,847 | 66,834 | 67.3 K to 66.8 K (-0.74 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.70 | 186 | 1,060 | 67,334 | 67.5 K to 67.3 K (-0.28 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.71 | 14 | 80 | 67,520 | 67.5 K to 67.5 K (-0.02 %) |
Oct 17 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.72 | 1,000 | 5,723 | 67,534 | 68.5 K to 67.5 K (-1.46 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.24 | 1,398 | 8,724 | 238,160 | 239.6 K to 238.2 K (-0.58 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.22 | 1,940 | 12,067 | 239,558 | 241.5 K to 239.6 K (-0.80 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.21 | 6,676 | 41,458 | 241,498 | 248.2 K to 241.5 K (-2.69 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.20 | 58 | 360 | 248,174 | 248.2 K to 248.2 K (-0.02 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.19 | 995 | 6,159 | 248,232 | 249.2 K to 248.2 K (-0.40 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.18 | 1,258 | 7,774 | 249,227 | 250.5 K to 249.2 K (-0.50 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.17 | 1,869 | 11,532 | 250,485 | 252.4 K to 250.5 K (-0.74 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.16 | 506 | 3,117 | 252,354 | 252.9 K to 252.4 K (-0.20 %) |
Oct 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 6.15 | 300 | 1,845 | 252,860 | 253.2 K to 252.9 K (-0.12 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.35 | 100 | 535 | 253,160 | 253.3 K to 253.2 K (-0.04 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.34 | 99 | 529 | 253,260 | 253.4 K to 253.3 K (-0.04 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.33 | 300 | 1,599 | 253,359 | 253.7 K to 253.4 K (-0.12 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.32 | 196 | 1,043 | 253,659 | 253.9 K to 253.7 K (-0.08 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.32 | 7,603 | 40,448 | 253,855 | 261.5 K to 253.9 K (-2.91 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.31 | 803 | 4,264 | 261,458 | 262.3 K to 261.5 K (-0.31 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.30 | 2,702 | 14,321 | 262,261 | 265 K to 262.3 K (-1.02 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.27 | 429 | 2,261 | 264,963 | 265.4 K to 265 K (-0.16 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.26 | 1,068 | 5,618 | 265,392 | 266.5 K to 265.4 K (-0.40 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.25 | 299 | 1,570 | 266,460 | 266.8 K to 266.5 K (-0.11 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.24 | 100 | 524 | 266,759 | 266.9 K to 266.8 K (-0.04 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.23 | 100 | 523 | 266,859 | 267 K to 266.9 K (-0.04 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.22 | 500 | 2,610 | 266,959 | 267.5 K to 267 K (-0.19 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.21 | 601 | 3,131 | 267,459 | 268.1 K to 267.5 K (-0.22 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.20 | 100 | 520 | 268,060 | 268.2 K to 268.1 K (-0.04 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 80,800 | |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 68,534 | 83.5 K to 68.5 K (-17.96 %) |
Sep 06 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 83,534 | 68.5 K to 83.5 K (+21.89 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.28 | 7,900 | 41,712 | 268,160 | 276.1 K to 268.2 K (-2.86 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.27 | 1,500 | 7,905 | 276,060 | 277.6 K to 276.1 K (-0.54 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.26 | 100 | 526 | 277,560 | 277.7 K to 277.6 K (-0.04 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.24 | 100 | 524 | 277,660 | 277.8 K to 277.7 K (-0.04 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.23 | 800 | 4,184 | 277,760 | 278.6 K to 277.8 K (-0.29 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.22 | 1,500 | 7,830 | 278,560 | 280.1 K to 278.6 K (-0.54 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.21 | 2,400 | 12,504 | 280,060 | 282.5 K to 280.1 K (-0.85 %) |
Aug 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.20 | 700 | 3,640 | 282,460 | 283.2 K to 282.5 K (-0.25 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.23 | 250 | 1,308 | 68,534 | 68.8 K to 68.5 K (-0.36 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.22 | 200 | 1,044 | 68,784 | 69 K to 68.8 K (-0.29 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.22 | 1,000 | 5,216 | 68,984 | 70 K to 69 K (-1.43 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.21 | 550 | 2,866 | 69,984 | 70.5 K to 70 K (-0.78 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.17 | 200 | 1,034 | 70,534 | 70.7 K to 70.5 K (-0.28 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.16 | 1,630 | 8,411 | 70,734 | 72.4 K to 70.7 K (-2.25 %) |
Aug 29 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.15 | 1,170 | 6,026 | 72,364 | 73.5 K to 72.4 K (-1.59 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 15,000 | 54,150 | 95,800 | |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.60 | 15,000 | 84,000 | 73,534 | 88.5 K to 73.5 K (-16.94 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 15,000 | 54,150 | 88,534 | 73.5 K to 88.5 K (+20.40 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 4.99 | 500 | 2,495 | 73,534 | 74 K to 73.5 K (-0.68 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.02 | 500 | 2,510 | 74,034 | 74.5 K to 74 K (-0.67 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.04 | 1,500 | 7,560 | 74,534 | 76 K to 74.5 K (-1.97 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.09 | 1,500 | 7,635 | 76,034 | 77.5 K to 76 K (-1.93 %) |
Jul 30 2012 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 5.12 | 1,000 | 5,120 | 77,534 | 78.5 K to 77.5 K (-1.27 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.29 | 300 | 1,587 | 283,160 | 283.5 K to 283.2 K (-0.11 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.28 | 100 | 528 | 283,460 | 283.6 K to 283.5 K (-0.04 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.27 | 359 | 1,892 | 283,560 | 283.9 K to 283.6 K (-0.13 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.26 | 2,500 | 13,150 | 283,919 | 286.4 K to 283.9 K (-0.87 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.25 | 1,600 | 8,400 | 286,419 | 288 K to 286.4 K (-0.56 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.24 | 4,100 | 21,484 | 288,019 | 292.1 K to 288 K (-1.40 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.24 | 100 | 524 | 292,119 | 292.2 K to 292.1 K (-0.03 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.23 | 100 | 523 | 292,219 | 292.3 K to 292.2 K (-0.03 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.23 | 1,927 | 10,078 | 292,319 | 294.2 K to 292.3 K (-0.65 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.22 | 100 | 522 | 294,246 | 294.3 K to 294.2 K (-0.03 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.22 | 1,473 | 7,689 | 294,346 | 295.8 K to 294.3 K (-0.50 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.22 | 100 | 522 | 295,819 | 295.9 K to 295.8 K (-0.03 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.21 | 400 | 2,084 | 295,919 | 296.3 K to 295.9 K (-0.13 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.21 | 100 | 521 | 296,319 | 296.4 K to 296.3 K (-0.03 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.20 | 200 | 1,040 | 296,419 | 296.6 K to 296.4 K (-0.07 %) |
Jul 03 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.20 | 1,541 | 8,013 | 296,619 | 298.2 K to 296.6 K (-0.52 %) |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | A | 5.03 | 10,000 | 50,300 | 10,000 | |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | A | 5.03 | 50,000 | 251,500 | 50,000 | |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 5.03 | 10,000 | 50,300 | 10,000 | |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 5.03 | 10,000 | 50,300 | 10,000 | |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | A | 5.03 | 10,000 | 50,300 | 10,000 | |
Jun 25 2012 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | A | 5.03 | 10,000 | 50,300 | 10,000 | |
Jun 19 2012 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 5.00 | 15,000 | 75,000 | 298,160 | 313.2 K to 298.2 K (-4.79 %) |
Jan 04 2012 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 2.84 | 2,234 | 6,345 | 162,219 | 164.5 K to 162.2 K (-1.36 %) |
Oct 04 2011 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 4.35 | 2,234 | 9,718 | 87,453 | 89.7 K to 87.5 K (-2.49 %) |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 15,000 | 0 | 1,610,742 | 1.6 M to 1.6 M (-0.92 %) |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 150,000 | 0 | 350,000 | 200 K to 350 K (+75.00 %) |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 0.00 | 75,000 | 0 | 164,453 | 89.5 K to 164.5 K (+83.84 %) |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Dec 12 2011 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 50,000 | 0 | 76,534 | 26.5 K to 76.5 K (+188.44 %) |
Sep 13 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Option Exercise | M | 3.00 | 2,500 | 7,500 | 141,709 | |
Sep 13 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 6.00 | 2,500 | 15,000 | 0 | 2.5 K to 0 (-100.00 %) |
Sep 13 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Buy | M | 3.00 | 2,500 | 7,500 | 2,500 | 0 to 2.5 K |
Jul 11 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Option Exercise | M | 5.19 | 4,000 | 20,760 | 57,068 | |
Jul 11 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Sell | S | 6.47 | 4,000 | 25,880 | 0 | 4 K to 0 (-100.00 %) |
Jul 11 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Buy | M | 5.19 | 4,000 | 20,760 | 4,000 | 0 to 4 K |
Jul 11 2011 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 5.94 | 300,000 | 1,782,000 | 300,000 | |
Jul 05 2011 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 5.89 | 2,234 | 13,158 | 89,687 | 91.9 K to 89.7 K (-2.43 %) |
Jul 05 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 144,209 | |
Jul 05 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 6.00 | 15,000 | 90,000 | 0 | 15 K to 0 (-100.00 %) |
Jul 05 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Buy | M | 3.45 | 15,000 | 51,750 | 15,000 | 0 to 15 K |
Jun 08 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Option Exercise | M | 5.19 | 4,000 | 20,760 | 61,068 | |
Jun 08 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Sell | S | 6.52 | 4,000 | 26,080 | 0 | 4 K to 0 (-100.00 %) |
Jun 08 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Buy | M | 5.19 | 4,000 | 20,760 | 4,000 | 0 to 4 K |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | WIGGANS THOMAS G | Director | Option Exercise | A | 6.41 | 10,000 | 64,100 | 10,000 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 159,209 | |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 6.80 | 13,894 | 94,479 | 0 | 13.9 K to 0 (-100.00 %) |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 6.81 | 1,000 | 6,810 | 13,894 | 14.9 K to 13.9 K (-6.71 %) |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 6.82 | 106 | 723 | 14,894 | 15 K to 14.9 K (-0.71 %) |
Jun 03 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Buy | M | 3.45 | 15,000 | 51,750 | 15,000 | 0 to 15 K |
May 09 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Option Exercise | M | 5.19 | 4,000 | 20,760 | 65,068 | |
May 09 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Sell | S | 6.74 | 4,000 | 26,960 | 0 | 4 K to 0 (-100.00 %) |
May 09 2011 | SGMO | SANGAMO BIOSCIENCE ... | Ichikawa David G | Senior VP, Bus. Dev ... | Buy | M | 5.19 | 4,000 | 20,760 | 4,000 | 0 to 4 K |
May 04 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 174,209 | |
May 04 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 7.35 | 100 | 735 | 0 | 100 to 0 (-100.00 %) |
May 04 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 7.34 | 7,400 | 54,316 | 100 | 7.5 K to 100 (-98.67 %) |
May 04 2011 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | CSO & Vice Presiden ... | Sell | S | 7.34 | 2,200 | 16,137 | 7,500 | 9.7 K to 7.5 K (-22.68 %) |